- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr Frank James on the Role of Stigma in Addiction Treatment
It is important to treat addiction as a chronic disease and to address the stigmatization of both the addiction and the treatments we have available to treat it, said Dr Frank James, MD, JD, of American Society of Addiction Medicine.
Transcript
What is the role of stigma and how does it prevent people from getting treatment?
One aspect of approaching this epidemic is getting rid of the stigmatization of addiction and opioid addiction. It’s important to realize that people that have an opioid addiction, it’s not a moral problem or a problem of not wanting to get better or stay clean and sober. It is a chemical process in the brain. It can be treated with medication assistant treatments. Anyone can be addicted to an opioid. It can be your neighbor, your teacher. It crosses all socioeconomic barriers, and so once we approach it as a chronic disease and realize that there are treatments for this, then the stigma about having addiction goes away. So, we really need to address the stigmatization of both the addiction and the stigmatization of the treatments we have that are available to help people with this problem.
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Key Indicators of Myasthenia Gravis Disease Progression Reduced With Efgartigimod
April 18th 2025Research presented at the recent annual meeting of the Academy of Managed Care Pharmacy highlights outcomes among patients who have anti-acetylcholine receptor antibody-positive myasthenia gravis that include reduced exacerbations and need for immunoglobulin.
Read More
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
Bias Reduction, Better Access Key to COVID-19 Equity Gains
April 14th 2025Interventions that target enhancing health care equity among communities disproportionately affected by the COVID-19 pandemic can be improved by including comprehensive needs assessments at the patient, provider, and health system levels.
Read More
Orca-T showed lower rates of graft-vs-host disease or infection compared with allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome (MDS) or acute leukemias in the Precision-T trial, Caspian Oliai, MD, MS, UCLA Bone Marrow Transplantation Stem Cell Processing Center, said.
Read More
